Jonathan Young - Net Worth and Insider Trading
Jonathan Young Net Worth
The estimated net worth of Jonathan Young is at least $9 Million dollars as of 2024-07-16. Jonathan Young is the COO of Akero Therapeutics Inc and owns about 306,854 shares of Akero Therapeutics Inc (AKRO) stock worth over $9 Million. Details can be seen in Jonathan Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jonathan Young has not made any transactions after 2024-07-01 and currently still holds the listed stock(s).
Transaction Summary of Jonathan Young
Jonathan Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Young owns 1 companies in total, including Akero Therapeutics Inc (AKRO) .
Click here to see the complete history of Jonathan Young’s form 4 insider trades.
Insider Ownership Summary of Jonathan Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-07-01 | Chief Operating Officer |
Jonathan Young Latest Holdings Summary
Jonathan Young currently owns a total of 1 stock. Jonathan Young owns 306,854 shares of Akero Therapeutics Inc (AKRO) as of July 1, 2024, with a value of $9 Million.
Latest Holdings of Jonathan Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2024-07-01 | 306,854 | 28.04 | 8,604,186 |
Holding Weightings of Jonathan Young
Jonathan Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Young has made a total of 21 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 21 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 5,000 shares on July 1, 2024, which brought Jonathan Young around $117,000.
Insider Trading History of Jonathan Young
- 1
Jonathan Young Trading Performance
Jonathan Young Ownership Network
Jonathan Young Owned Company Details
What does Akero Therapeutics Inc do?
Who are the key executives at Akero Therapeutics Inc?
Jonathan Young is the Chief Operating Officer of Akero Therapeutics Inc. Other key executives at Akero Therapeutics Inc include Chief Scientific Officer Timothy Rolph , See Remarks Patrick Lamy , and Chief Development Officer Catriona Yale .
Akero Therapeutics Inc (AKRO) Insider Trades Summary
Over the past 18 months, Jonathan Young made 12 insider transaction in Akero Therapeutics Inc (AKRO) with a net sale of 60,714. Other recent insider transactions involving Akero Therapeutics Inc (AKRO) include a net sale of 316,764 shares made by Andrew Cheng , a net sale of 70,093 shares made by Catriona Yale , and a net purchase of 1,320,000 shares made by G. Walmsley Graham .
In summary, during the past 3 months, insiders sold 34,015 shares of Akero Therapeutics Inc (AKRO) in total and bought 0 shares, with a net sale of 34,015 shares. During the past 18 months, 623,074 shares of Akero Therapeutics Inc (AKRO) were sold and 1,320,000 shares were bought by its insiders, resulting in a net purchase of 696,926 shares.
Akero Therapeutics Inc (AKRO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akero Therapeutics Inc Insider Transactions
Jonathan Young Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Young. You might contact Jonathan Young via mailing address: C/o Akero Therapeutics, Inc., 170 Harbor Way 3rd Fl, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
